Lower rates of deep vein thrombosis have been noted following total hip replacement under epidural anesthesia in patients receiving exogenous epinephrine throughout surgery. To determine whether this is due to enhanced fibrinolysis or to circulatory effects of epinephrine, 30 patients scheduled for primary total hip replacement under epidural anesthesia were randomly assigned to receive intravenous infusions of either low dose epinephrine or phenylephrine intraoperatively. All patients received lumbar epidural anesthesia with induced hypotension and were monitored with radial artery and pulmonary artery catheters.
Patients receiving low dose epinephrine infusion had maintenance of heart rate and cardiac index whereas both heart rate and cardiac index declined significantly throughout surgery in patients receiving phenylephrine (p = 0.0001 and p = 0.0001, respectively). Tissue plasminogen activator (t-PA) activity increased significantly during surgery (p <0.0005) and declined below baseline postoperatively (p <0.005) in both groups. Low dose epinephrine was not associated with any additional augmentation of fibrinolytic activity perioperatively. There were no significant differences in changes in D-Dimer, t-PA antigen, α2-plasmin inhibitor-plasmin complexes or thrombin-antithrombin III complexes perioperatively between groups receiving low dose epinephrine or phenylephrine. The reduction in deep vein thrombosis rate with low dose epinephrine is more likely mediated by a circulatory mechanism than by augmentation of fibrinolysis.
REFERENCES
1
Sharrock NE,
Ranawat CS,
Urquhart B.
Factors influencing deep vein thrombosis following total hip arthroplasty under hypotensive anesthesia. Reg Anesth 1991; 15: 33
2
Modig J.
Influence of regional anesthesia, local anesthetics, and sympathicomimetics on the pathophysiology of deep vein thrombosis. Acta Chir Scand Suppl 1988; 550: 119-127
4
Sung BH,
Robinson C,
Thadani U,
Lee R,
Wilson MF.
Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: Dose response studies. Clin Pharmacol Ther 1988; 43: 308-316
7
Ogawa S,
Gerlach H,
Esposito C,
Pasagian-Macaulay A,
Brett J,
Stern D.
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 1990; 85: 1090-1098
9
Rosing DR,
Redweed D,
Brakman P,
Astrup T,
Epstein SE.
The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res 1978; 13: 419-428
10
Sharrock NE,
Mineo R,
Urquhart B.
Hemodynamic response to low-dose epinephrine infusion during hypotensive epidural anesthesia for total hip replacement. Reg Anesth 1990; 15: 295-299
13
Suffredini AF,
Harpel PC,
Parrillo JE.
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin administration to normal subjects. N Engl J Med 1989; 320: 1165-1172
14
Davis FM,
McDermott E,
Hickton C,
Wells E,
Heaton DC,
Laurenson VG,
Gillespie WJ,
Foate J.
Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth 1987; 59: 561-571
15
Modig J,
Borg T,
Bagge L,
Saldeen T.
Role of extradural and of general anaesthesia in fibrinolysis and coagulant after total hip replacement. Br J Anaesth 1983; 55: 625-629
17
Hansen J-B,
Wilsgard L,
Olsen JO,
Osterus B.
Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemostas 1990; 64: 385-389
18
Urano T,
Cho M,
Takahashi S,
Sumiyoshi K,
Nakamura M,
Mori T,
Takada Y,
Takada A.
Changes of parameters in fibrinolytic system caused by mental stress. Thromb Res 1990; 60: 501-507
20
Urano T,
Sumiyoshi K,
Nakamura M,
Mori T,
Takada Y,
Takada A.
Fluctuation of TPA and PAI-1 antigen levels in plasma: Difference of their fluctuation patterns between male and female. Thromb Haemostas 1990; 60: 133-139
22
Rydzewski A,
Sakata K,
Kobayashi A,
Yamazaki N,
Urano T,
Takada Y,
Takada A.
Changes in plasminogen activator 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease. Haemostasis 1990; 20: 305-312
26
Sikorski JM,
Hampson WG,
Staddon GE.
The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Jt Surg (Br) 1981; 63-B: 171-177
28
Sharrock NE,
Brien WW,
Salvati EA,
Mineo R,
Garvin K,
Sculco TP.
The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis: A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Jt Surg (Am) 1990; 72-A: 1456-1461
29
Prins MH,
Hirsh J.
A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: A critical review. Thromb Haemostas 1990; 64: 497-500
30
Sharrock NE,
Haas SB,
Hargett MJ,
Urquhart B,
Insall JN,
Scuderi G.
Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Jt Surg (Am) 1991; 73: 502-506
32
Davis GM,
Laurenson VG,
Gillespie WJ,
Foate J,
Seagar AD.
Leg blood flow during total hip replacement under spinal or general anaesthesia. Anaesth Intens Care 1989; 17: 136-143
35
Bowler GMR,
Lamont MC,
Scott DB.
Effect of extradural bupivacaine or I. V diamorphine on calf blood flow in patients after surgery. Br J Anaesth 1987; 59: 1412-1419
36
Freyschuss U,
Hjemdahl P,
Juhlin-Dannfelt A,
Linde B.
Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans. Clin Sci 1986; 70: 199-206
37
Comerota A,
Stewart G,
Alburger P,
Smalley K,
White J.
Operative venodilation: A previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 1989; 106: 301-309
39
Takeuchi M,
Nagura H,
Kaneda T.
DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood 1988; 72: 850-854
40
Bazzoni G,
Dejana E,
Del Maschio A.
Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine. Blood 1991; 77: 2042-2048
